⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21638056 | 1.00 | — | — | |
| SCHEMBL436504 | 0.92 | NOS3 (0.30) | — | |
| SCHEMBL254857 | 0.92 | NOS3 (0.30) | — | |
| SCHEMBL436177 | 0.92 | NOS3 (0.30) | — | |
| SCHEMBL15323288 | 0.86 | NOS3 (0.32) | — | |
| SCHEMBL23432355 | 0.82 | — | — | |
| SCHEMBL13892778 | 0.82 | — | — | |
| SCHEMBL13767601 | 0.80 | — | — | |
| SCHEMBL999487 | 0.78 | EPHX1 (0.32) | — | |
| SCHEMBL13480367 | 0.78 | LIPA (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11732153-B2 | Coating liquid composition and process for producing article provided with film using it | AGC Inc. (JP) | 2023-08-22 | — | — | US | disclosed |
| EP-3359625-B1 | CHIRAL COMPOUNDS | MERCK PATENT GMBH (DE) | 2019-10-23 | — | — | EP | disclosed |
| EP-2635274-B1 | ANTI-STAPHYLOCOCCAL CELECOXIB DERIVATIVES | UNIV OHIO STATE RES FOUND (US) | 2017-12-06 | — | — | EP | disclosed |
| WO-2017059942-A1 | CHIRAL COMPOUNDS | MERCK PATENT GMBH (DE) | 2017-04-13 | — | — | WO | disclosed |
| US-20150284636-A1 | LIQUID-CRYSTALLINE MEDIUM AND ELECTRO-OPTICAL LIQUID-CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2015-10-08 | — | — | US | disclosed |
| US-8715527-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2014-05-06 | — | — | US | disclosed |
| EP-2594270-A2 | The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) | BIP Patents (DE) | 2013-05-22 | — | — | EP | disclosed |
| EP-2457975-A2 | Liquid-crystalline mixtures | Merck Patent GmbH (DE) | 2012-05-30 | — | — | EP | disclosed |
| US-20110042615-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-02-24 | — | — | US | disclosed |
| US-7704566-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2010-04-27 | — | — | US | disclosed |
| US-7303791-B2 | Liquid crystals having a terminal polar radical and a terminal CH3 group and simultaneously having very high specific resistances and low threshold voltages requiring a high clearing point and low rotational viscosity; matrices | MERCK PATENT GMBH (DE) | 2007-12-04 | — | — | US | disclosed |
| US-20070269614-A1 | Containing at least two nitrile-free mesogenic compounds, one of which contains rings including a phenyl ring llinked by at least one -CF2O- group; electrooptical dispalys | HECKMEIER MICHAEL | 2007-11-22 | — | — | US | disclosed |
| US-7291367-B2 | Liquid-crystalline compounds | MERCK PATENT GMBH (DE) | 2007-11-06 | — | — | US | disclosed |
| US-20070237907-A1 | PHOTOSTABLE LIQUID-CRYSTALLINE MEDIUM | MANABE ATSUTAKA | 2007-10-11 | — | — | US | disclosed |
| US-7250198-B2 | For electrooptical display | MERCK PATENT GMBH (DE) | 2007-07-31 | — | — | US | disclosed |
| EP-1411104-B1 | Liquid crystalline compounds with a -CHFO- bridge | MERCK PATENT GMBH (DE) | 2007-05-16 | — | — | EP | disclosed |
| US-7211302-B2 | Photostable liquid crystalline medium | MERCK PATENT GMBH (DE) | 2007-05-01 | — | — | US | disclosed |
| US-7189440-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2007-03-13 | — | — | US | disclosed |
| US-7179511-B2 | For use in electro-optical displays | MERCK PATENT GMBH (DE) | 2007-02-20 | — | — | US | disclosed |
| US-20070001149-A1 | Liquid-crystal medium containing monofluoroterphenyl compounds | MERCK PATENT GMBH (DE) | 2007-01-04 | — | — | US | disclosed |